SI9300545A - Stable pharmaceutical formulation of a polyoxypropylene/polyoxyethylene block copolymer - Google Patents

Stable pharmaceutical formulation of a polyoxypropylene/polyoxyethylene block copolymer Download PDF

Info

Publication number
SI9300545A
SI9300545A SI9300545A SI9300545A SI9300545A SI 9300545 A SI9300545 A SI 9300545A SI 9300545 A SI9300545 A SI 9300545A SI 9300545 A SI9300545 A SI 9300545A SI 9300545 A SI9300545 A SI 9300545A
Authority
SI
Slovenia
Prior art keywords
container according
block copolymer
solution
molecular weight
daltons
Prior art date
Application number
SI9300545A
Other languages
English (en)
Slovenian (sl)
Inventor
Mary Sou
William Davis Craig
Green Floyd Alison
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SI9300545A publication Critical patent/SI9300545A/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/77Polymers containing oxygen of oxiranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Packages (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI9300545A 1992-10-19 1993-10-18 Stable pharmaceutical formulation of a polyoxypropylene/polyoxyethylene block copolymer SI9300545A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929221883A GB9221883D0 (en) 1992-10-19 1992-10-19 Novel formulation

Publications (1)

Publication Number Publication Date
SI9300545A true SI9300545A (en) 1994-06-30

Family

ID=10723654

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9300545A SI9300545A (en) 1992-10-19 1993-10-18 Stable pharmaceutical formulation of a polyoxypropylene/polyoxyethylene block copolymer

Country Status (19)

Country Link
EP (1) EP0671919A1 (ja)
JP (1) JPH08502284A (ja)
KR (1) KR950703345A (ja)
AU (1) AU674895B2 (ja)
BR (1) BR9307268A (ja)
CA (1) CA2147889A1 (ja)
CZ (1) CZ63395A3 (ja)
GB (1) GB9221883D0 (ja)
HU (1) HUT75701A (ja)
IL (1) IL107313A0 (ja)
MX (1) MX9306467A (ja)
NO (1) NO951462L (ja)
NZ (1) NZ256890A (ja)
PL (1) PL308459A1 (ja)
SI (1) SI9300545A (ja)
SK (1) SK44795A3 (ja)
TW (1) TW276183B (ja)
WO (1) WO1994008596A1 (ja)
ZA (1) ZA937714B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2185162A4 (en) * 2007-08-10 2012-04-25 Synthrx Inc POLYMER THERAPY FOR THE TREATMENT OF CHRONIC MICROVASCULAR DISEASES
CA2927361A1 (en) 2013-10-16 2015-04-23 Mast Therapeutics, Inc. Diuretic induced alterations of plasma volume
US9757411B2 (en) 2014-07-07 2017-09-12 Aires Pharmaceuticals, Inc. Poloxamer therapy for heart failure
EP3747448A1 (en) 2014-07-07 2020-12-09 LifeRaft Biosciences, Inc. A poloxamer composition free of long circulating material and methods for production and uses thereof
WO2016007542A1 (en) 2014-07-07 2016-01-14 Mast Therapeutics, Inc. Poloxamer therapy for heart failure
CN109432511A (zh) * 2018-12-29 2019-03-08 常州乐奥医疗科技股份有限公司 一种温敏型水凝胶及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641240A (en) * 1968-09-27 1972-02-08 Wyandotte Chemicals Corp Method for the treatment of an embolus or thrombus
DE3234084A1 (de) * 1982-09-14 1984-03-15 B. Braun Melsungen Ag, 3508 Melsungen Pharmazeutische zubereitungen zur behandlung von unerwuenschten verwachsungen sowie deren verwendung
US4879109A (en) * 1986-05-15 1989-11-07 Emory University Method for treating burns
US4938961A (en) * 1989-04-28 1990-07-03 Geoffrey Collins Organ preservation solution containing pokyethylene gycol and method of performing cardioplegia

Also Published As

Publication number Publication date
IL107313A0 (en) 1994-01-25
TW276183B (ja) 1996-05-21
SK44795A3 (en) 1996-05-08
KR950703345A (ko) 1995-09-20
CA2147889A1 (en) 1994-04-28
CZ63395A3 (en) 1995-07-12
HUT75701A (en) 1997-05-28
NZ256890A (en) 1995-10-26
WO1994008596A1 (en) 1994-04-28
EP0671919A1 (en) 1995-09-20
PL308459A1 (en) 1995-07-24
MX9306467A (es) 1994-05-31
NO951462L (no) 1995-06-13
HU9501104D0 (en) 1995-06-28
ZA937714B (en) 1995-04-18
GB9221883D0 (en) 1992-12-02
AU5284293A (en) 1994-05-09
JPH08502284A (ja) 1996-03-12
NO951462D0 (no) 1995-04-18
BR9307268A (pt) 1999-05-11
AU674895B2 (en) 1997-01-16

Similar Documents

Publication Publication Date Title
KR100884711B1 (ko) 외용 투여용 올로파타딘 제제
US20060127423A1 (en) Organic compounds
RU2462234C2 (ru) Способы стабилизации окислительно нестабильных композиций
JPH0735336B2 (ja) 動物あるいは人体中の脈管再建処置に伴う組織損傷防止用薬剤
PT1368019E (pt) Formulação de esmolol
US6436425B1 (en) Method and non-gelling composition for inhibiting post-surgical adhesions
AU2011264919A1 (en) Formulations including amiodarone and salts thereof and methods of their manufacture and use
SI9300545A (en) Stable pharmaceutical formulation of a polyoxypropylene/polyoxyethylene block copolymer
JPS60109523A (ja) 薬理学的活性ケトン化合物
JPH0525857B2 (ja)
EP1294369B1 (en) NOVEL FORMULATIONS OF $g(a)-2,4-DISULFOPHENYL-N-TERT-BUTYLNITRONE
RU2242231C2 (ru) Парентеральная композиция для лечения эпилепсии
JP2003517462A (ja) 複数回投与用エリスロポエチン製剤
EP4311539A1 (en) Imatinib formulation for parenteral administration
JP2946015B2 (ja) 安定な抗ウィルス点滴用注射剤
JPS61501148A (ja) 終末減菌し得る等張薬剤組成物
WO2014139677A1 (en) Parenteral formulation of fluoroquinolone antibacterial agent and method for preparation thereof
IL30719A (en) Physiological salt solutions of ethylene oxidepolypropylene glycol condensation products
MXPA00003413A (en) Parenteral formulations comprising carbamazepine or its derivatives
EP0342030A2 (en) Use of a thromboxane receptor antagonist to complement arterial surgery